Skip to main content
Figure 6 | BMC Pharmacology

Figure 6

From: Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling

Figure 6

Effects of SalB treatment on hemodynamic parameters. Maximum rate of pressure development (+dP/dtmax), maximum rate of relaxation (-dP/dtmin), end-diastolic pressure (EDP), mean arterial pressure (MAP), Left ventricular systolic pressure (LVSP) and cardiac output were demonstrated. All the values are expressed as mean ± S.E. *P < 0.05, ***P < 0.001 versus Sham rats; #P < 0.05, ##P < 0.01, ###P < 0.001 versus MI rats. n = 20 for every group.

Back to article page